137 related articles for article (PubMed ID: 805115)
1. Naphthomycin, a novel ansa macrocyclic antimetabolite. Proton NMR spectra and structure elucidation using lanthanide shift reagent.
Williams TH
J Antibiot (Tokyo); 1975 Jan; 28(1):85-6. PubMed ID: 805115
[No Abstract] [Full Text] [Related]
2. A new dipeptide antibiotic from Streptomyces collinus, Lindenbein.
Molloy BB; Lively DH; Gale RM; Gorman M; Boeck LD
J Antibiot (Tokyo); 1972 Feb; 25(2):137-40. PubMed ID: 4624614
[No Abstract] [Full Text] [Related]
3. [Metabolic products of microorganisms. 72. Naphthomycin, an antimetabolite of vitamin K].
Balerna M; Keller-Schierlein W; Martius C; Wolf H; Zähner H
Arch Mikrobiol; 1969; 65(4):303-17. PubMed ID: 4988744
[No Abstract] [Full Text] [Related]
4. New naphthyridinomycin-type antibiotics, aclidinomycins A and B, from Streptomyces halstedi.
Cang S; Ohta S; Chiba H; Johdo O; Nomura H; Nagamatsu Y; Yoshimoto A
J Antibiot (Tokyo); 2001 Mar; 54(3):304-7. PubMed ID: 11372787
[No Abstract] [Full Text] [Related]
5. A new ansamycin antibiotic, naphthomycin H from a Streptomyces species Y-83,40369.
Mukhopadhyay T; Franco CM; Reddy GC; Ganguli BN; Fehlhaber HW
J Antibiot (Tokyo); 1985 Jul; 38(7):948-51. PubMed ID: 4030505
[No Abstract] [Full Text] [Related]
6. Naphthyridinomycin, a new broad-spectrum antibiotic.
Kluepfel D; Baker HA; Piattoni G; Sehgal SN; Sidorowicz A; Singh K; Vézina C
J Antibiot (Tokyo); 1975 Jul; 28(7):497-502. PubMed ID: 807549
[TBL] [Abstract][Full Text] [Related]
7. Metabolic products of microorganisms 137. Rinamycin, a new inhibitor of RNA synthesis.
Uchida K; Zähner H
J Antibiot (Tokyo); 1975 Mar; 28(3):185-93. PubMed ID: 805116
[TBL] [Abstract][Full Text] [Related]
8. Antimetabolites produced by microorganisms. XV synthesis of 2-methyl-arginine, 2-methyl-l-ornithine and their enantiomers.
Maehr H; Yarmchuk L; Kellett M; Palleroni NJ; La Prosser B; Demny TC
J Antibiot (Tokyo); 1976 Mar; 29(3):213-20. PubMed ID: 816762
[TBL] [Abstract][Full Text] [Related]
9. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106. II. Structure determination and structure-activity relationships.
Hayashi K; Nakagawa M; Fujita T; Tanimori S; Nakayama M
J Antibiot (Tokyo); 1994 Oct; 47(10):1110-5. PubMed ID: 7961160
[TBL] [Abstract][Full Text] [Related]
10. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106.
Hayashi K; Nakagawa M; Fujita T; Tanimori S; Nakayama M
J Antibiot (Tokyo); 1993 Dec; 46(12):1904-7. PubMed ID: 8294252
[No Abstract] [Full Text] [Related]
11. Isolation and structural elucidation of naphthomycins B and C.
Keller-Schierlein W; Meyer M; Zeeck A; Damberg M; Machinek R; Zähner H; Lazar G
J Antibiot (Tokyo); 1983 May; 36(5):484-92. PubMed ID: 6874565
[TBL] [Abstract][Full Text] [Related]
12. A new antibiotic X-5108 OF Streptomyces origin. I. Production, isolation and properties.
Berger J; Lehr H; Teitel S; Maehr H; Grunberg E
J Antibiot (Tokyo); 1973 Jan; 26(1):15-22. PubMed ID: 4781274
[No Abstract] [Full Text] [Related]
13. [R-(Z)]-4-amino-3-chloro-2-pentenedioic acid, a new antibiotic. Fermentation, isolation and characterization.
Chaiet L; Arison BH; Monaghan RL; Springer JP; Smith JL; Zimmerman SB
J Antibiot (Tokyo); 1984 Mar; 37(3):207-10. PubMed ID: 6427163
[TBL] [Abstract][Full Text] [Related]
14. A new olivanic acid derivative produced by Streptomyces olivaceus: isolation and structural studies.
Box SJ; Corbett DF; Robins KG; Spear SR; Verrall MS
J Antibiot (Tokyo); 1982 Oct; 35(10):1394-6. PubMed ID: 6983522
[No Abstract] [Full Text] [Related]
15. Antimetabolites produced by microorganisms. XI. 1-(S)-hydroxy-2-(S,S)-valylamido-cyclobutane-1-acetic acid.
Pruess DL; Scannell JP; Blount JF; Ax HA; Kellett M; Williams TH; Stempel A
J Antibiot (Tokyo); 1974 Oct; 27(10):754-9. PubMed ID: 4218225
[No Abstract] [Full Text] [Related]
16. L-1,4-cyclohexadiene-1-alanine, an antagonist of phenylalanine from Streptomyces.
Yamashita T; Miyairi N; Kunugita K; Shimizu K; Sakai H
J Antibiot (Tokyo); 1970 Nov; 23(11):537-41. PubMed ID: 4992169
[No Abstract] [Full Text] [Related]
17. Abbeymycin, a new anthramycin-type antibiotic produced by a streptomycete.
Hochlowski JE; Andres WW; Theriault RJ; Jackson M; McAlpine JB
J Antibiot (Tokyo); 1987 Feb; 40(2):145-8. PubMed ID: 3570962
[TBL] [Abstract][Full Text] [Related]
18. Studies on pentenomycins. I. Production, isolation and properties of pentenomycins I and II, new antibiotics from Streptomyces eurythermus MCRL 0738.
Umino K; Furumai T; Matsuzawa N; Awataguchi Y; Ito Y
J Antibiot (Tokyo); 1973 Sep; 26(9):506-12. PubMed ID: 4792064
[No Abstract] [Full Text] [Related]
19. beta-Ethynylserine, an antimetabolite of L-threonine, from Streptomyces cattleya.
Sanada M; Miyano T; Iwadare S
J Antibiot (Tokyo); 1986 Feb; 39(2):304-5. PubMed ID: 3082841
[No Abstract] [Full Text] [Related]
20. Bioconversion of ribostamycin (SF-733). II. Isolation and structure of 3-N-acetylribostamycin, a microbiologically inactive product of ribostamycin produced by Streptomyces ribosidificus.
Kojima M; Ezaki N; Amano S; Inouye S; Nida T
J Antibiot (Tokyo); 1975 Jan; 28(1):42-7. PubMed ID: 805112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
